For: | Wang YG, Huang PP, Zhang R, Ma BY, Zhou XM, Sun YF. Targeting adeno-associated virus and adenoviral gene therapy for hepatocellular carcinoma. World J Gastroenterol 2016; 22(1): 326-337 [PMID: 26755879 DOI: 10.3748/wjg.v22.i1.326] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v22/i1/326.htm |
Number | Citing Articles |
1 |
Adrianne L. Jenner, Chae-Ok Yun, Peter S. Kim, Adelle C. F. Coster. Mathematical Modelling of the Interaction Between Cancer Cells and an Oncolytic Virus: Insights into the Effects of Treatment Protocols. Bulletin of Mathematical Biology 2018; 80(6): 1615 doi: 10.1007/s11538-018-0424-4
|
2 |
Changhoon Choi, Gyu Sang Yoo, Won Kyung Cho, Hee Chul Park. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World Journal of Gastroenterology 2019; 25(20): 2416-2429 doi: 10.3748/wjg.v25.i20.2416
|
3 |
Saeed Ali, Sameer Prakash, Arvind R. Murali. Hepatic Manifestations of Nonhepatotropic Infectious Agents Including Severe Acute Respiratory Syndrome Coronavirus-2, Adenovirus, Herpes Simplex Virus, and Coxiella burnetii. Gastroenterology Clinics of North America 2021; 50(2): 383 doi: 10.1016/j.gtc.2021.02.012
|
4 |
Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abe, Shuji Terai. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. Cancers 2019; 11(12): 1865 doi: 10.3390/cancers11121865
|
5 |
Bijay Dhungel, Charmaine A. Ramlogan-Steel, Christopher J. Layton, Jason C. Steel. MicroRNA199a-Based Post-transcriptional Detargeting of Gene Vectors for Hepatocellular Carcinoma. Molecular Therapy - Nucleic Acids 2018; 13: 78 doi: 10.1016/j.omtn.2018.08.016
|
6 |
Payal Deepak, Rajinikanth Siddalingam, Praveen Kumar, Sneha Anand, Sunita Thakur, Balasubramaniam Jagdish, Shweta Jaiswal. Gene based nanocarrier delivery for the treatment of hepatocellular carcinoma. Journal of Drug Delivery Science and Technology 2020; 59: 101837 doi: 10.1016/j.jddst.2020.101837
|
7 |
M. Aravintha Siva, R. Mahalakshmi, Dipita Bhakta-Guha, Gunjan Guha. Gene therapy for the mitochondrial genome: Purging mutations, pacifying ailments. Mitochondrion 2019; 46: 195 doi: 10.1016/j.mito.2018.06.002
|
8 |
Adel Galal El-Shemi, Ahmad Mohammed Ashshi, Youjin Na, Yan Li, Mohammed Basalamah, Faisal Ahmad Al-Allaf, Eonju Oh, Bo-Kyeong Jung, Chae-Ok YUN. Combined therapy with oncolytic adenoviruses encoding TRAIL and IL-12 genes markedly suppressed human hepatocellular carcinoma both in vitro and in an orthotopic transplanted mouse model. Journal of Experimental & Clinical Cancer Research 2016; 35(1) doi: 10.1186/s13046-016-0353-8
|
9 |
Adrian Kuzmanović, Cheng Lin, Matthias Bartneck. Hepatobiliary Cancers: An Interdisciplinary Approach. Interdisciplinary Cancer Research 2023; 3: 283 doi: 10.1007/16833_2023_129
|
10 |
Yonggan Ji, Hongli Fan, Mengmeng Yang, Changcai Bai, Wen Yang, Zhisheng Wang. Synergistic Effect of Baculovirus-Mediated Endostatin and Angiostatin Combined with Gemcitabine in Hepatocellular Carcinoma. Biological and Pharmaceutical Bulletin 2022; 45(3): 309 doi: 10.1248/bpb.b21-00857
|
11 |
Patrick L. Mulcrone, Roland W. Herzog, Weidong Xiao. Adding recombinant AAVs to the cancer therapeutics mix. Molecular Therapy - Oncolytics 2022; 27: 73 doi: 10.1016/j.omto.2022.09.009
|
12 |
Yuwei Li, Yinan Shen, Ronghua Zhao, Ismael Samudio, William Jia, Xueli Bai, Tingbo Liang. Oncolytic virotherapy in hepato‐bilio‐pancreatic cancer: The key to breaking the log jam?. Cancer Medicine 2020; 9(9): 2943 doi: 10.1002/cam4.2949
|
13 |
A Galal El-Shemi, A Mohammed Ashshi, E Oh, B-K Jung, M Basalamah, A Alsaegh, C-O Yun. Efficacy of combining ING4 and TRAIL genes in cancer-targeting gene virotherapy strategy: first evidence in preclinical hepatocellular carcinoma. Gene Therapy 2018; 25(1): 54 doi: 10.1038/gt.2017.86
|
14 |
Kenneth Lundstrom. Latest Trends in Cancer Therapy Applying Viral Vectors. Future Virology 2017; 12(11): 667 doi: 10.2217/fvl-2017-0070
|
15 |
Fang Huang, Bin-Rong Wang, Ye-Qing Wu, Fan-Chao Wang, Jian Zhang, Yi-Gang Wang. Oncolytic viruses against cancer stem cells: A promising approach for gastrointestinal cancer. World Journal of Gastroenterology 2016; 22(35): 7999-8009 doi: 10.3748/wjg.v22.i35.7999
|
16 |
Huiling Tian, Long Cheng, Yunhui Liang, Hongyuan Lei, Miaomiao Qin, Xinyun Li, Yongshen Ren. MicroRNA therapeutic delivery strategies: A review. Journal of Drug Delivery Science and Technology 2024; 93: 105430 doi: 10.1016/j.jddst.2024.105430
|
17 |
Saranya Chidambaranathan Reghupaty, Devanand Sarkar. Current Status of Gene Therapy in Hepatocellular Carcinoma. Cancers 2019; 11(9): 1265 doi: 10.3390/cancers11091265
|
18 |
Adrianne Jenner, Adelle Coster, Peter Kim, Federico Frascoli. Treating Cancerous Cells with Viruses: Insights from Aminimal Model for Oncolytic Virotherapy. Letters in Biomathematics 2018; 5(2) doi: 10.30707/LiB5.2Jenner
|
19 |
Fang Huang, Bing-Rong Wang, Yi-Gang Wang. Role of autophagy in tumorigenesis, metastasis, targeted therapy and drug resistance of hepatocellular carcinoma. World Journal of Gastroenterology 2018; 24(41): 4643-4651 doi: 10.3748/wjg.v24.i41.4643
|
20 |
Alisha M. Gruntman, Terence R. Flotte. The rapidly evolving state of gene therapy. The FASEB Journal 2018; 32(4): 1733 doi: 10.1096/fj.201700982R
|
21 |
Subhajit Pathak, Vijayata Singh, Narendra Kumar, Giridhara R. Jayandharan. Inducible caspase 9-mediated suicide gene therapy using AAV6 vectors in a murine model of breast cancer. Molecular Therapy - Methods & Clinical Development 2023; 31: 101166 doi: 10.1016/j.omtm.2023.101166
|
22 |
Marianna Hösel, Anke Huber, Susanne Bohlen, Julie Lucifora, Giuseppe Ronzitti, Francesco Puzzo, Florence Boisgerault, Ulrich T. Hacker, Wilhelmus J. Kwanten, Nora Klöting, Matthias Blüher, Alexander Gluschko, Michael Schramm, Olaf Utermöhlen, Wilhelm Bloch, Federico Mingozzi, Oleg Krut, Hildegard Büning. Autophagy determines efficiency of liver‐directed gene therapy with adeno‐associated viral vectors. Hepatology 2017; 66(1): 252 doi: 10.1002/hep.29176
|
23 |
Xue Yang, Shuangshuang Li, Huiju Wang, Wanyuan Chen, Xiaozhou Mou, Shibing Wang. Expression of coxsackie and adenovirus receptor is correlated with inferior prognosis in liver cancer patients. Oncology Letters 2018; doi: 10.3892/ol.2018.9868
|
24 |
Licheng Zhu, Yu Lei, Jia Huang, Yahang An, Yanqiao Ren, Lei Chen, Huangxuan Zhao, Chuansheng Zheng. Recent advances in oncolytic virus therapy for hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1172292
|
25 |
Jian Zhang, Weijie Lai, Qiang Li, Yang Yu, Jin Jin, Wan Guo, Xiumei Zhou, Xinyuan Liu, Yigang Wang. A novel oncolytic adenovirus targeting Wnt signaling effectively inhibits cancer-stem like cell growth via metastasis, apoptosis and autophagy in HCC models. Biochemical and Biophysical Research Communications 2017; 491(2): 469 doi: 10.1016/j.bbrc.2017.07.041
|
26 |
Taicheng Lu, Zhenzhen Nong, Liying Wei, Mei Wei, Guo Li, Nini Wu, Cheng Liu, Bingling Tang, Qixiao Qin, Xuehua Li, Fayan Meng. Preparation and anti-cancer activity of transferrin/folic acid double-targeted graphene oxide drug delivery system. Journal of Biomaterials Applications 2020; 35(1): 15 doi: 10.1177/0885328220913976
|
27 |
Bryan Mckiver, Mohamad Imad Damaj, Devanand Sarkar. Assessment of Current Gene Therapy Practices in Hepatocellular Carcinoma. Gastrointestinal Disorders 2020; 2(4): 469 doi: 10.3390/gidisord2040042
|
28 |
Linwen Zhu, Tianwen Li, Yijing Shen, Xiuchong Yu, Bingxiu Xiao, Junming Guo. Using tRNA halves as novel biomarkers for the diagnosis of gastric cancer. Cancer Biomarkers 2019; 25(2): 169 doi: 10.3233/CBM-182184
|
29 |
Eesha Chakraborty, Devanand Sarkar. Emerging Therapies for Hepatocellular Carcinoma (HCC). Cancers 2022; 14(11): 2798 doi: 10.3390/cancers14112798
|
30 |
Wenhua He, Qingxuan Li, Yan Lu, Dingyue Ju, Yu Gu, Kai Zhao, Chuanming Dong. Cancer Treatment Evolution from Traditional Methods to Stem Cells and
Gene Therapy. Current Gene Therapy 2022; 22(5): 368 doi: 10.2174/1566523221666211119110755
|
31 |
Jialiang Wang, Huan Wei, Yanlin Huang, Dongmei Chen, Guofen Zeng, Yifan Lian, Yuehua Huang. The combination of lonafarnib and sorafenib induces cyclin D1 degradation via ATG3-mediated autophagic flux in hepatocellular carcinoma cells. Aging 2019; 11(15): 5769 doi: 10.18632/aging.102165
|
32 |
Nusrat Khan, Sridhar Bammidi, Sourav Chattopadhyay, Giridhara R. Jayandharan. Combination Suicide Gene Delivery with an Adeno-Associated Virus Vector Encoding Inducible Caspase-9 and a Chemical Inducer of Dimerization Is Effective in a Xenotransplantation Model of Hepatocellular Carcinoma. Bioconjugate Chemistry 2019; 30(6): 1754 doi: 10.1021/acs.bioconjchem.9b00291
|
33 |
Jeong Heo, Ja-Der Liang, Chang Won Kim, Hyun Young Woo, I-Lun Shih, Tung-Hung Su, Zhong-Zhe Lin, So Young Yoo, Stanley Chang, Yasuo Urata, Pei-Jer Chen. Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial. Molecular Therapy 2023; 31(7): 2077 doi: 10.1016/j.ymthe.2023.04.006
|
34 |
Pavel Marichal-Gallardo, Kathleen Börner, Michael M. Pieler, Vera Sonntag-Buck, Martin Obr, David Bejarano, Michael W. Wolff, Hans-Georg Kräusslich, Udo Reichl, Dirk Grimm. Single-Use Capture Purification of Adeno-Associated Viral Gene Transfer Vectors by Membrane-Based Steric Exclusion Chromatography. Human Gene Therapy 2021; 32(17-18): 959 doi: 10.1089/hum.2019.284
|